Wednesday, June 10, 2026
🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
2,004

Quick answer

2,004 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 6132729

    Combined tissue factor and chemotherapeutic methods and compositions for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6129914

    Bispecific antibody effective to treat B-cell lymphoma and cell line

    Protein Design Labs, Inc. · Granted Tue Oct 10 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6123941

    Method for restoration of normal phenotype in cancer cells

    The Regents of the University of California · Granted Tue Sep 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6114397

    Gossypol for the treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6114110

    Isolation and propagation of a human herpesvirus derived from AIDS-associated Kaposi's sarcoma cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Sep 05 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6110889

    Peptide tumor cell growth inhibitors

    The Board of Regents of the University of Texas System · Granted Tue Aug 29 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6107540

    Mice models of human prostate cancer progression

    The Regents of the University of California · Granted Tue Aug 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6096520

    Brain glycogen phosphorylase cancer antigen

    The Regents of the University of California · Granted Tue Aug 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6096534

    Retrovirus vectors derived from avian sarcoma leukosis viruses permitting transfer of genes into mammalian cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 01 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6090795

    Human derived monocyte attracting purified peptide products useful in a method of treating infection and neoplasms in a human body

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6090365

    Radioimmunotherapy of lymphoma using anti-CD20 antibodies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6087110

    Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 11 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6084069

    Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6083703

    Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6071949

    Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6069283

    Illudin analogs useful as antitumor agents

    The Regents of the University of California · Granted Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6060310

    Transcription factor decoy and tumor growth inhibitor

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6060505

    Method of treating cancer using C-26 modified bryostatin

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 09 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6057300

    Methods for treating cancers and restenosis with p21

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 02 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6051218

    Tumor radiosensitization using gene therapy

    The Regents of the University of California · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6051387

    Methods of determining the presence of a neoplasm with CLNH5- and CLNH11-specific antibodies

    The Regents of the University of California · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6051229

    Human-human hybridom for neoplasms CLNH5 and CLNH11 specific antibody compositions

    The Regents of the University of California · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6051230

    Compositions for targeting the vasculature of solid tumors

    The Board of Regents of the University of Texas System · Granted Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6046241

    .beta.-alethine as anti-tumor agent

    The Regents of the University of New Mexico · Granted Tue Apr 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6045789

    Bystander effect tumoricidal therapy by expressing an HSV-tk gene

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Apr 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6042829

    Biotherapy of cancer by targeting TP-3/P80

    Regents of the University of Minnesota · Granted Tue Mar 28 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6040334

    Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in cancer therapy

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6037337

    Use of the enantiomers of ifosfamide in antitumor therapy for reducing side effects

    Darwin Discovery Limited · Granted Tue Mar 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6037376

    Methods for therapy of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 14 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6033905

    Gibbon ape leukemia virus-based retroviral vectors

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Mar 07 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6025328

    Antitumor agents

    The Regents of the University of California · Granted Tue Feb 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6017962

    Method of depletion of methionine in plasma and solid tumors and uses thereof

    The Board of Regents of the University of Texas System · Granted Tue Jan 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6017524

    Inhibiting the growth p53 deficient tumor cells by administering the p53 gene

    The Board of Regents of the University of Texas System · Granted Tue Jan 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6015811

    Antitumor Chrysene derivatives

    The Board of Regents of the University of Texas System · Granted Tue Jan 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6015542

    Radioimmunotherapy of lymphoma using anti-CD20 antibodies

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6013807

    Antitumor tetracyclic compounds

    University College Cardiff Consultants Limited · Granted Tue Jan 11 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many Oncology patents are indexed?

2,004 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.